WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 36 filers reported holding WEREWOLF THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STATE STREET CORP | 50,768 | $108,644 | 0.00% |
Edgewood Management | 50,000 | $107,000 | 0.00% |
ROYAL BANK OF CANADA | 335 | $1,000 | 0.00% |
VANGUARD GROUP INC | 547,651 | $1,171,973 | 0.00% |
Qube Research & Technologies Ltd | 2 | $4 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 58,128 | $124,394 | 0.00% |
BANK OF AMERICA CORP /DE/ | 1,531,924 | $3,278,318 | 0.00% |
WELLS FARGO & COMPANY/MN | 146 | $312 | 0.00% |
NORTHERN TRUST CORP | 26,067 | $55,783 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 1,000 | $2,140 | 0.00% |
PRUDENTIAL FINANCIAL INC | 15,400 | $32,956 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 174,250 | $373,006 | 0.00% |
BlackRock Inc. | 77,113 | $165,022 | 0.00% |
GHP Investment Advisors, Inc. | 80 | $185 | 0.00% |
JPMORGAN CHASE & CO | 748 | $1,601 | 0.00% |
External links
This page lists WEREWOLF THERAPEUTICS INC's shareholders in Q3 2023. To view WEREWOLF THERAPEUTICS INC's shareholder history, click here.